UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: July 2, 2024
Accession Number: 0001104659-24-075714
Submission Type: POS AM
CIK: 0001173281
Company Name: NeuBase Therapeutics, Inc.
File Number: 333-257327